Monarch Labs

What’s “new” in wound treatment

 

17875 Sky Park Circle, Suite K; Irvine, CA 92614

Phone: 949-679-3000 / Fax: 949-679-3001

www.MonarchLabs.com   sales@MonarchLabs.com


Press
Releases

 

Press Releases and Announcements




January 30, 2007 - PRESS RELEASE

MONARCH LABS COMPLETES MEDICAL DEVICE FACILITY EXPANSION

Irvine, CA – January 29, 2007 - Monarch Labs, LLC. announced today that it has completed the expansion of its new insectary facility. Monarch Labs produces and distributes Medical Maggots™, a medical device for wound debridement (cleaning) in human and other animals. The newly completed insectary allows for fly and maggot breeding capacity four times greater than its previous laboratory. Monarch Labs undertook the expansion of its production facilities to meet the medical and veterinary communities’ growing need for Medical Maggots™ for maggot debridement therapy. The company already serves over 500 customers throughout the U.S. and Canada.

Medical Maggots™ are living fly larvae used in maggot debridement therapy for treating chronic, non-healing necrotic skin and soft-tissue wounds, including pressure ulcers (bed sores), venous stasis ulcers, neuropathic foot ulcers (like diabetic foot ulcers), and non-healing traumatic or post surgical wounds. Since these live maggots (also known as larvae) must be maintained germ-free and starving, they are highly perishable. Medical Maggots™ must be produced daily from fresh fly eggs, delivered to customers within 48 hours, and used within 24 hours of delivery.

Monarch Labs’ Medical Director, Dr. Ronald Sherman, stated, “Our new state-of-the-art insectary is already producing nearly half a million eggs per week, and we are only operating at 50% capacity. With capabilities to produce up to a thousand vials of Medical Maggots™ per week (one million eggs), Monarch Labs will now have the capacity and flexibility to respond to dramatic increases in medical demands for our product within 24 hours.”

Monarch Labs’ insectary was designed by the company’s entomologist and laboratory technicians, and constructed by Carey Construction of Irvine, CA.

About Monarch Labs LLC.
Monarch Labs is the exclusive supplier of Medical MaggotsTM (disinfected Phaenicia sericata larvae) for maggot debridement therapy. Medical MaggotsTM represents the first live organism to be granted marketing clearance by the FDA as a medical device. Learn more about Monarch Labs and Medical MaggotsTM at www.MonarchLabs.com or contact:

Ronald A. Sherman, MD, MSc
Medical Director
Monarch Labs
17875 Sky Park Circle, Suite K
Irvine, CA 92614
Phone: 949-679-3000
Fax: 949-679-3001
RSherman@MonarchLabs.com



January 18, 2007 - Announcement
Maggot Therapy Workshop scheduled for March 9, 2007

Monarch Labs is proud to support the BTER Foundation's next Maggot Therapy Workshop, to be held in Irvine, CA on March 9, 2007. If you attend the workshop, please plan to join us at Monarch Labs that day for an open house and tour. (Sorry, we do not give public tours, due to the need to prevent potential contamination in the laboratory. This is a one-time event for workshop attendees, only.)



January 10, 2007 - Announcement
Veterinarians Save Horse with Maggot Debridement Therapy

Veterinarians at Oklahoma State University used maggot therapy to treat a horse bitten by a rattlesnake. An extensive area of the neck necrosed, compromising the animal’s breathing (despite a tracheostomy and intravenous antibiotics). Three cycles of maggot therapy were applied, the wound began to heal, and she was released from the hospital. You can read more about this amazing story at: Oklahoma State University web site.




October 31, 2006 - Announcement
CBS Channel 2 News Story on Maggot Therapy

CBS Channel 2 News recently paid a visit to Monarch Labs.
See their video about maggot therapy and listen to what therapists and patients say on their news documentary.
To view their video, Press Here.



September 1, 2006 - Announcement
Maggot Therapy used to treat problematic wounds at the National Institutes of Medicine

Doctors at the National Institutes of Medicine describe one of the patients treated with maggot therapy in the July 20, 2004 issue of The NIH Record. He developed a large wound on the inner thigh which failed multiple medical and surgical attempts to close it. After a year of unsuccessful efforts to heal the wound, he was finally treated with maggot therapy which led to debridement and healing of his wound. You can read the story at: http://www.nih.gov/nihrecord/07_20_2004/main.htm.




NOTE:

 

Medical Maggots™ are indicated for use in the care and treatment of chronic wounds ("wound care") of humans or other animals for the following indications:

 

For debriding non-healing necrotic skin and soft tissue wounds, including pressure ulcers, venous stasis ulcers, neuropathic foot ulcers and non-healing traumatic or post surgical wounds.

 

 

Medical Maggots™ are used to clean ("debride") and manage wounds in a procedure known as "maggot therapy." Sometimes wound debridement using maggots is also called "maggot debridement therapy," "MDT," "larva therapy," "larval therapy," "larva debridement therapy," or "biodebridement."


In the United States, Medical Maggots™ are regulated by the Food and Drug Administration as a prescription only medical device used in the care and treatment of wounds. Read all packing information carefully.

 



Home Page

History of
Maggot Therapy

Veterinary
MDT

Maggot Therapy Info & Links

Press Releases & Announcements

To Order
Medical Maggots

Download Price List & order form

Read or Download Package Insert

Educational Slides

How to make
MDT Dressings

Reimbursement Information

Virtual Tour of Monarch Labs

Frequently asked Questions

Report AE’s

Contact info


 

Copyright © 2006 by Monarch Labs. All Rights Reserved.